Therapeutic Potential of TLR8 Agonist GS‐9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators
Oliver E. Amin, Emily J. Colbeck, Stephane Daffis, Shahzada Khan, Dhivya Ramakrishnan, Divya Pattabiraman, Ruth Chu, Holly Micolochick Steuer, Sophie Lehar, Leanne Peiser, Adam Palazzo, Christian Frey, Jessica Davies, Hassan Javanbakht, William M.C. Rosenberg, Simon P. Fletcher, Mala K. Maini, Laura J. Pallett – 25 December 2020